FinData: News for VSE, MBI - Med Biogene Inc

Friday, 24 May 2013

Med Biogene Inc

Recent News

MED BIOGENE INC. : Comments on Market Activity
08:50 | 19/5/13

4-traders
VANCOUVER, BRITISH COLUMBIA -- Med BioGene Inc. (TSX VENTURE:MBI) today, at the request of the Investment Industry Regulatory Organization of Canada (IIROC), announced that Med BioGene's management is unaware of any material change in the ... more»
Med BioGene Inc is Featured as the Daily Momentum Gainer to Watch on ...
03:02 | 15/5/13

Stockhouse
Toronto, Ontario--(Newsfile Corp. - May 14, 2013) - Leading smallcap investor portal Smallcappower is pleased to highlight Med BioGene Inc (TSXV: MBI) as their Daily Momentum Gainer to watch. You can see the chart and view the analyst's summary here: ... more»
MED BIOGENE INC. : Med BioGene Announces Adoption of Advance Notice ...
07:18 | 19/4/13

4-traders
VANCOUVER, BRITISH COLUMBIA--Med BioGene Inc. (TSX VENTURE:MBI) today announced that its board of directors (the "Board") has adopted an Advance Notice Policy (the "Policy"). more»
MED BIOGENE INC. : Med BioGene Announces Date of Annual and Special ...
07:18 | 19/4/13

4-traders
VANCOUVER, BRITISH COLUMBIA-- Med BioGene Inc. (TSX VENTURE:MBI) today announced the date of its upcoming annual and special meeting of shareholders ("Annual Meeting"). more»
Med BioGene Announces Adoption of Advance Notice Policy
07:01 | 19/4/13

SYS-CON Media
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/18/13 -- Med BioGene Inc. (TSX VENTURE:MBI) today announced that its board of directors (the "Board") has adopted an Advance Notice Policy (the "Policy"). more»
Med Biogene Provides Update on Litigation With Signal Genetics LLC and ...
02:31 | 26/2/13

Marketwire
25, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today provided an update in regard to its ongoing litigation with Signal Genetics LLC and Respira Health LLC. more»
Precision Therapeutics and Med BioGene Announce Successful Completion of ...
22:44 | 25/1/13

Melodika.net
Precision Therapeutics, Inc. and Med BioGene Inc. (TSX VENTURE:MBI) today announced that Precision Therapeutics has successfully completed their previously announced clinical studies to validate the use of LungExpress Dx™ with tissue preserved by ... more»
Precision Therapeutics and Med BioGene Announce Successful Completion of ...
02:32 | 24/1/13

MarketWatch
PITTSBURGH, PENNSYLVANIA AND VANCOUVER, BRITISH COLUMBIA, Jan 23, 2013 (MARKETWIRE via COMTEX) -- Precision Therapeutics, Inc. and Med BioGene Inc. (CVE:CA:MBI) today announced that Precision Therapeutics has successfully ... more»
Med Biogene Inc And Precision Therapeutics, Inc. Completes LungExpress Dx Clinical Studies
02:30 | 24/1/13

Reuters Key Development
Med Biogene Inc And Precision Therapeutics, Inc. Completes LungExpress Dx Clinical Studies more»
Med BioGene Posts No Revenues in Q3 as Partner Validates Test
05:22 | 1/12/12

GenomeWeb
The firm recently amended a deal with Precision Therapeutics covering the commercialization of Med BioGene's LungExpress Dx gene expression-based test for early stage non-small cell lung cancer by mid-2013. more»

Global Indices

Code	Last	Change
NZ50	4,589	22	0.47%
COMP	3,463	39	1.11%
DJI	15,307	80	0.52%
SP500	1,652	4	0.22%
DAX	7,789	91	1.15%
FTSE	6,840	36	0.53%
NI225	12,494	22	0.18%
TWI	76.67	0.29	0.38%

More news...

No news available...

Currencies

Code	Last	Change
EURUSD	1.293	0.009	0.73%
NZDUSD	0.8142	0.0079	0.98%
AUDUSD	0.9733	0.0062	0.64%
NZDAUD	0.8362	0.0045	0.54%